ELI LILLY AND COMPANY Dividends Declared
ELI LILLY AND COMPANY (LLY) reported Dividends Declared of $2.23 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-20.
Discontinued › Shareholders' Equity
us-gaap:Dividends · last filed 2018-02-20
- ELI LILLY AND COMPANY dividends for fiscal 2017 was $2.23B, a 3.09% increase from fiscal 2016.
- ELI LILLY AND COMPANY dividends for fiscal 2016 was $2.17B, a 1.48% increase from fiscal 2015.
- ELI LILLY AND COMPANY dividends for fiscal 2015 was $2.14B, a 1.32% increase from fiscal 2014.
- ELI LILLY AND COMPANY dividends for fiscal 2014 was $2.11B, a 0.25% increase from fiscal 2013.
| Period end | Dividends 12 month |
|---|---|
| 2017-12-31 | $2.23B 10-K · filed 2018-02-20 |
| 2016-12-31 | $2.17B 10-K · filed 2018-02-20 |
| 2015-12-31 | $2.14B 10-K · filed 2018-02-20 |
| 2014-12-31 | $2.11B 10-K · filed 2017-02-21 |
| 2013-12-31 | $2.10B 10-K · filed 2016-02-19 |
| 2012-12-31 | $2.19B 10-K · filed 2015-02-19 |
| 2011-12-31 | $2.18B 10-K · filed 2014-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |